<code id='EF314AC7A9'></code><style id='EF314AC7A9'></style>
    • <acronym id='EF314AC7A9'></acronym>
      <center id='EF314AC7A9'><center id='EF314AC7A9'><tfoot id='EF314AC7A9'></tfoot></center><abbr id='EF314AC7A9'><dir id='EF314AC7A9'><tfoot id='EF314AC7A9'></tfoot><noframes id='EF314AC7A9'>

    • <optgroup id='EF314AC7A9'><strike id='EF314AC7A9'><sup id='EF314AC7A9'></sup></strike><code id='EF314AC7A9'></code></optgroup>
        1. <b id='EF314AC7A9'><label id='EF314AC7A9'><select id='EF314AC7A9'><dt id='EF314AC7A9'><span id='EF314AC7A9'></span></dt></select></label></b><u id='EF314AC7A9'></u>
          <i id='EF314AC7A9'><strike id='EF314AC7A9'><tt id='EF314AC7A9'><pre id='EF314AC7A9'></pre></tt></strike></i>

          Home / fashion / explore

          explore


          explore

          author:knowledge    Page View:77519
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In